These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38739083)

  • 21. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ventricular function in hypertrophic cardiomyopathy. Systolic and diastolic ventricular function].
    Olbrich HG; Kaltenbach M; Hopf R
    Fortschr Med; 1992 Sep; 110(27):481-4. PubMed ID: 1427543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodynamic changes due to single and coupled stimulation in patients with obstructive cardiomyopathy].
    Hassenstein P; Walther H; Dittrich J
    Verh Dtsch Ges Inn Med; 1975; 81():170-3. PubMed ID: 1241744
    [No Abstract]   [Full Text] [Related]  

  • 25. Midodrine hydrochloride and unexpected improvement in hypertrophic cardiomyopathy symptoms.
    Lafitte S; Peyrou J; Reynaud A; Dijos M; Cornolle C; Roudaut R; Touche C; Ritter P; Réant P
    Arch Cardiovasc Dis; 2016 Mar; 109(3):223-5. PubMed ID: 26898633
    [No Abstract]   [Full Text] [Related]  

  • 26. HEART DISEASE. Throttling back the heart's molecular motor.
    Warshaw DM
    Science; 2016 Feb; 351(6273):556-7. PubMed ID: 26912685
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
    Paulus WJ; Lorell BH; Craig WE; Wynne J; Murgo JP; Grossman W
    J Am Coll Cardiol; 1983 Nov; 2(5):879-86. PubMed ID: 6685150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
    Wang AA; Gu FS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
    [No Abstract]   [Full Text] [Related]  

  • 29. Abnormal diastolic flow patterns in hypertrophic cardiomyopathy: evaluation by simultaneous Doppler echocardiography, cineangiography, and hemodynamics.
    Silverman PR; Ten Cate FJ; Serruys PW; Roelandt JR
    J Am Soc Echocardiogr; 1989; 2(5):346-9. PubMed ID: 2629875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 32. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment?
    Maron BJ
    J Am Coll Cardiol; 1996 Feb; 27(2):431-2. PubMed ID: 8557916
    [No Abstract]   [Full Text] [Related]  

  • 33. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
    Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
    Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
    Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac pacemaker for the treatment of obstructive hypertrophic cardiomyopathy, a concept which is gaining ground].
    Kappenberger L; Jeanrenaud X; Aebischer N
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1950-5. PubMed ID: 7481653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
    Hegde SM; Lester SJ; Solomon SD; Michels M; Elliott PM; Nagueh SF; Choudhury L; Zemanek D; Zwas DR; Jacoby D; Wang A; Ho CY; Li W; Sehnert AJ; Olivotto I; Abraham TP
    J Am Coll Cardiol; 2021 Dec; 78(25):2518-2532. PubMed ID: 34915982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of short-term administration of verapamil on left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy.
    TenCate FJ; Serruys PW; Mey S; Roelandt J
    Circulation; 1983 Dec; 68(6):1274-9. PubMed ID: 6685582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of propranolol infusion on cyclic variation of myocardial integrated backscatter in hypertrophic obstructive cardiomyopathy.
    Ito T; Suwa M; Kobashi A; Nakamura T; Miyazaki S; Imai M; Kitaura Y
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1251-5. PubMed ID: 12411913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effects of intravenous verapamil in patients with obstructive myocardiopathy].
    Picó-Aracil F; Ruipérez JA; García Alberola A; Molina E; Ruiz-Ros JA; Campos JV; García J; Jaén E
    Rev Esp Cardiol; 1988 Jan; 41(1):16-21. PubMed ID: 3353560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.